glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Glutathione depletion and dihydroorotate dehydrogenase
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




